Skip to content
Saturday 25 July 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
City PM

European business, markets and politics

FTSE 100
10,736.23
+0.91%
DAX
25,099.00
+1.36%
CAC 40
8,372.28
+0.88%
STOXX 50
6,280.94
+1.14%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Wednesday 03 December 2014 10:28 am  |  Updated:  Friday 07 June 2019 5:45 pm

Parkinson’s app uMotif is the first app to be prescribed on the NHS

By: Emma Haslett

Add as a preferred source on Google

The NHS has just started prescribing its first app – from now on, patients with conditions such as diabetes, heart failure and Parkinsons can use uMotif, developed by a London-based startup, to monitor their health,

The app works by monitoring patients' blood pressure, blood glucose – and even includes a pedometer. Using the data it gets from them, it can issue patients with reminders, and help doctors to assess how well they are doing between appointments. To get access to it, patients are given a code on their prescription, and they can then download it from the iTunes or Android app store.

With the popularity of apps like MyFitnessPal, not to mention FitBug-style activity trackers, the logging of daily activity has become a pretty common thing. uMotif chief executive Bruce Hellman said we're at the "tipping point where digital health is about to start exploding and technology can really help to put people at the heart of their care".

At the moment, the app is being trialled for treatment of Parkinson's and diabetes, but it will be widened out across 17 NHS organisations. The idea is that it helps clinicians to develop on the NHS National Information Board's plans to "put patents at the centre of their care using technology" (although we'd hope patients were at the centre of their care already…).

The app can even link in with other healthcare applications, like Microsoft HealthVault. So following that £12bn IT bungle which crippled the NHS back in 2011, it looks like the service is finally getting its teeth into technology…

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • NHS

Trending Articles

  • BT braces for loss of 800,000 customers as it banks on fibre to keep turnaround ‘on track’

  • Wise denied US banking licence in blow to expansion plans

  • Regulator flags BDO’s ‘unacceptable’ audit issues for fifth year in a row 

  • Housebuilder hits a wall: How did Vistry become the UK’s most shorted stock?

  • Scotch whisky sales are falling, but what’s really behind the decline?

More from City PM

  • New Victoria Hospital Goes Live with MEDITECH Expanse to Deliver New Era of Care

    Business Wire
  • Dompé Doses First Patient in Phase 3 Study of Cenegermin-bkbj in NAION

    Business Wire
  • Almirall Announces EMA Acceptance for Filing of Paediatric Registration of Ebglyss (Lebrikizumab) in Atopic Dermatitis in Children 6 Months and Older

    Business Wire
  • Curaleaf Launches Free CPD-Accredited Platform to Close Medical Cannabis Training Gap for UK Healthcare Professionals

    Business Wire
  • Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform

    Business Wire
  • Almirall H1 2026 Results

    Business Wire
  • Patent cliff fuels Novartis’ $1.5bn swoop for London biotech

    Healthcare
    Hikma produces generic drugs
CityPM

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About City PM
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 City PM Ltd · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook